Industry Research Reports
Global Viral Inactivation Market Research Report 2025
Industry: Service & Software
Published Date: 2025-02-27
Pages: 83 Pages
Report ld: 4322621
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Viral Inactivation Market Size(US$)
CAGR 2025-2031
10.1%
Market Size,2031
USD 1,177
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 662 million
Market Forecast in 2031(Value)
US$ 1,177 million
CAGR
10.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Viral Inactivation was valued at US$ 607 million in the year 2024 and is projected to reach a revised size of US$ 1177 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
This report aims to provide a comprehensive presentation of the global market for Viral Inactivation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Inactivation.
The Viral Inactivation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Inactivation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Inactivation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
By Company
- Danaher
- Merck
- Parker Hannifin
- Sartorius
- SGS
- Charles River Laboratories International
- Clean Cells
- Rad Source Technologies
- Texcell
- Viral Inactivated Plasma Systems
- Wuxi Pharmatech (Cayman)
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Kits and Reagents
- Services
- Viral Inactivation Systems and Accessories
Segment by Application
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Stem Cell Products
- Tissue and Tissue Products
- Vaccines and Therapeutics
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Inactivation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Inactivation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Kits and Reagents
1.2.3 Services
1.2.4 Viral Inactivation Systems and Accessories
1.3 Market by Application
1.3.1 Global Viral Inactivation Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Blood and Blood Products
1.3.3 Cellular and Gene Therapy Products
1.3.4 Stem Cell Products
1.3.5 Tissue and Tissue Products
1.3.6 Vaccines and Therapeutics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Inactivation Market Perspective (2020-2031)
2.2 Global Viral Inactivation Growth Trends by Region
2.2.1 Global Viral Inactivation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Viral Inactivation Historic Market Size by Region (2020-2025)
2.2.3 Viral Inactivation Forecasted Market Size by Region (2026-2031)
2.3 Viral Inactivation Market Dynamics
2.3.1 Viral Inactivation Industry Trends
2.3.2 Viral Inactivation Market Drivers
2.3.3 Viral Inactivation Market Challenges
2.3.4 Viral Inactivation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Inactivation Players by Revenue
3.1.1 Global Top Viral Inactivation Players by Revenue (2020-2025)
3.1.2 Global Viral Inactivation Revenue Market Share by Players (2020-2025)
3.2 Global Viral Inactivation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral Inactivation Revenue
3.4 Global Viral Inactivation Market Concentration Ratio
3.4.1 Global Viral Inactivation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Inactivation Revenue in 2024
3.5 Global Key Players of Viral Inactivation Head office and Area Served
3.6 Global Key Players of Viral Inactivation, Product and Application
3.7 Global Key Players of Viral Inactivation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Inactivation Breakdown Data by Type
4.1 Global Viral Inactivation Historic Market Size by Type (2020-2025)
4.2 Global Viral Inactivation Forecasted Market Size by Type (2026-2031)
5 Viral Inactivation Breakdown Data by Application
5.1 Global Viral Inactivation Historic Market Size by Application (2020-2025)
5.2 Global Viral Inactivation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Viral Inactivation Market Size (2020-2031)
6.2 North America Viral Inactivation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Viral Inactivation Market Size by Country (2020-2025)
6.4 North America Viral Inactivation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Inactivation Market Size (2020-2031)
7.2 Europe Viral Inactivation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Viral Inactivation Market Size by Country (2020-2025)
7.4 Europe Viral Inactivation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Inactivation Market Size (2020-2031)
8.2 Asia-Pacific Viral Inactivation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Viral Inactivation Market Size by Region (2020-2025)
8.4 Asia-Pacific Viral Inactivation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Inactivation Market Size (2020-2031)
9.2 Latin America Viral Inactivation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Viral Inactivation Market Size by Country (2020-2025)
9.4 Latin America Viral Inactivation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Inactivation Market Size (2020-2031)
10.2 Middle East & Africa Viral Inactivation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Viral Inactivation Market Size by Country (2020-2025)
10.4 Middle East & Africa Viral Inactivation Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Details
11.1.2 Danaher Business Overview
11.1.3 Danaher Viral Inactivation Introduction
11.1.4 Danaher Revenue in Viral Inactivation Business (2020-2025)
11.1.5 Danaher Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Viral Inactivation Introduction
11.2.4 Merck Revenue in Viral Inactivation Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Parker Hannifin
11.3.1 Parker Hannifin Company Details
11.3.2 Parker Hannifin Business Overview
11.3.3 Parker Hannifin Viral Inactivation Introduction
11.3.4 Parker Hannifin Revenue in Viral Inactivation Business (2020-2025)
11.3.5 Parker Hannifin Recent Development
11.4 Sartorius
11.4.1 Sartorius Company Details
11.4.2 Sartorius Business Overview
11.4.3 Sartorius Viral Inactivation Introduction
11.4.4 Sartorius Revenue in Viral Inactivation Business (2020-2025)
11.4.5 Sartorius Recent Development
11.5 SGS
11.5.1 SGS Company Details
11.5.2 SGS Business Overview
11.5.3 SGS Viral Inactivation Introduction
11.5.4 SGS Revenue in Viral Inactivation Business (2020-2025)
11.5.5 SGS Recent Development
11.6 Charles River Laboratories International
11.6.1 Charles River Laboratories International Company Details
11.6.2 Charles River Laboratories International Business Overview
11.6.3 Charles River Laboratories International Viral Inactivation Introduction
11.6.4 Charles River Laboratories International Revenue in Viral Inactivation Business (2020-2025)
11.6.5 Charles River Laboratories International Recent Development
11.7 Clean Cells
11.7.1 Clean Cells Company Details
11.7.2 Clean Cells Business Overview
11.7.3 Clean Cells Viral Inactivation Introduction
11.7.4 Clean Cells Revenue in Viral Inactivation Business (2020-2025)
11.7.5 Clean Cells Recent Development
11.8 Rad Source Technologies
11.8.1 Rad Source Technologies Company Details
11.8.2 Rad Source Technologies Business Overview
11.8.3 Rad Source Technologies Viral Inactivation Introduction
11.8.4 Rad Source Technologies Revenue in Viral Inactivation Business (2020-2025)
11.8.5 Rad Source Technologies Recent Development
11.9 Texcell
11.9.1 Texcell Company Details
11.9.2 Texcell Business Overview
11.9.3 Texcell Viral Inactivation Introduction
11.9.4 Texcell Revenue in Viral Inactivation Business (2020-2025)
11.9.5 Texcell Recent Development
11.10 Viral Inactivated Plasma Systems
11.10.1 Viral Inactivated Plasma Systems Company Details
11.10.2 Viral Inactivated Plasma Systems Business Overview
11.10.3 Viral Inactivated Plasma Systems Viral Inactivation Introduction
11.10.4 Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2020-2025)
11.10.5 Viral Inactivated Plasma Systems Recent Development
11.11 Wuxi Pharmatech (Cayman)
11.11.1 Wuxi Pharmatech (Cayman) Company Details
11.11.2 Wuxi Pharmatech (Cayman) Business Overview
11.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Introduction
11.11.4 Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2020-2025)
11.11.5 Wuxi Pharmatech (Cayman) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Viral Inactivation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Kits and Reagents
Table 3. Key Players of Services
Table 4. Key Players of Viral Inactivation Systems and Accessories
Table 5. Global Viral Inactivation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Viral Inactivation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Viral Inactivation Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Viral Inactivation Market Share by Region (2020-2025)
Table 9. Global Viral Inactivation Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Viral Inactivation Market Share by Region (2026-2031)
Table 11. Viral Inactivation Market Trends
Table 12. Viral Inactivation Market Drivers
Table 13. Viral Inactivation Market Challenges
Table 14. Viral Inactivation Market Restraints
Table 15. Global Viral Inactivation Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Viral Inactivation Market Share by Players (2020-2025)
Table 17. Global Top Viral Inactivation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2024)
Table 18. Ranking of Global Top Viral Inactivation Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Viral Inactivation Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Viral Inactivation, Headquarters and Area Served
Table 21. Global Key Players of Viral Inactivation, Product and Application
Table 22. Global Key Players of Viral Inactivation, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Viral Inactivation Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Viral Inactivation Revenue Market Share by Type (2020-2025)
Table 26. Global Viral Inactivation Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Viral Inactivation Revenue Market Share by Type (2026-2031)
Table 28. Global Viral Inactivation Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Viral Inactivation Revenue Market Share by Application (2020-2025)
Table 30. Global Viral Inactivation Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Viral Inactivation Revenue Market Share by Application (2026-2031)
Table 32. North America Viral Inactivation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Viral Inactivation Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Viral Inactivation Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Viral Inactivation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Viral Inactivation Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Viral Inactivation Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Viral Inactivation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Viral Inactivation Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Viral Inactivation Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Viral Inactivation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Viral Inactivation Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Viral Inactivation Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Viral Inactivation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Viral Inactivation Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Viral Inactivation Market Size by Country (2026-2031) & (US$ Million)
Table 47. Danaher Company Details
Table 48. Danaher Business Overview
Table 49. Danaher Viral Inactivation Product
Table 50. Danaher Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 51. Danaher Recent Development
Table 52. Merck Company Details
Table 53. Merck Business Overview
Table 54. Merck Viral Inactivation Product
Table 55. Merck Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 56. Merck Recent Development
Table 57. Parker Hannifin Company Details
Table 58. Parker Hannifin Business Overview
Table 59. Parker Hannifin Viral Inactivation Product
Table 60. Parker Hannifin Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 61. Parker Hannifin Recent Development
Table 62. Sartorius Company Details
Table 63. Sartorius Business Overview
Table 64. Sartorius Viral Inactivation Product
Table 65. Sartorius Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 66. Sartorius Recent Development
Table 67. SGS Company Details
Table 68. SGS Business Overview
Table 69. SGS Viral Inactivation Product
Table 70. SGS Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 71. SGS Recent Development
Table 72. Charles River Laboratories International Company Details
Table 73. Charles River Laboratories International Business Overview
Table 74. Charles River Laboratories International Viral Inactivation Product
Table 75. Charles River Laboratories International Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 76. Charles River Laboratories International Recent Development
Table 77. Clean Cells Company Details
Table 78. Clean Cells Business Overview
Table 79. Clean Cells Viral Inactivation Product
Table 80. Clean Cells Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 81. Clean Cells Recent Development
Table 82. Rad Source Technologies Company Details
Table 83. Rad Source Technologies Business Overview
Table 84. Rad Source Technologies Viral Inactivation Product
Table 85. Rad Source Technologies Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 86. Rad Source Technologies Recent Development
Table 87. Texcell Company Details
Table 88. Texcell Business Overview
Table 89. Texcell Viral Inactivation Product
Table 90. Texcell Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 91. Texcell Recent Development
Table 92. Viral Inactivated Plasma Systems Company Details
Table 93. Viral Inactivated Plasma Systems Business Overview
Table 94. Viral Inactivated Plasma Systems Viral Inactivation Product
Table 95. Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 96. Viral Inactivated Plasma Systems Recent Development
Table 97. Wuxi Pharmatech (Cayman) Company Details
Table 98. Wuxi Pharmatech (Cayman) Business Overview
Table 99. Wuxi Pharmatech (Cayman) Viral Inactivation Product
Table 100. Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 101. Wuxi Pharmatech (Cayman) Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Viral Inactivation Picture
Figure 2. Global Viral Inactivation Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Viral Inactivation Market Share by Type: 2024 VS 2031
Figure 4. Kits and Reagents Features
Figure 5. Services Features
Figure 6. Viral Inactivation Systems and Accessories Features
Figure 7. Global Viral Inactivation Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Viral Inactivation Market Share by Application: 2024 VS 2031
Figure 9. Blood and Blood Products Case Studies
Figure 10. Cellular and Gene Therapy Products Case Studies
Figure 11. Stem Cell Products Case Studies
Figure 12. Tissue and Tissue Products Case Studies
Figure 13. Vaccines and Therapeutics Case Studies
Figure 14. Viral Inactivation Report Years Considered
Figure 15. Global Viral Inactivation Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Viral Inactivation Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Viral Inactivation Market Share by Region: 2024 VS 2031
Figure 18. Global Viral Inactivation Market Share by Players in 2024
Figure 19. Global Top Viral Inactivation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Viral Inactivation Revenue in 2024
Figure 21. North America Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Viral Inactivation Market Share by Country (2020-2031)
Figure 23. United States Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Viral Inactivation Market Share by Country (2020-2031)
Figure 27. Germany Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Viral Inactivation Market Share by Region (2020-2031)
Figure 35. China Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Viral Inactivation Market Share by Country (2020-2031)
Figure 43. Mexico Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Viral Inactivation Market Share by Country (2020-2031)
Figure 47. Turkey Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Viral Inactivation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Danaher Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 51. Merck Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 52. Parker Hannifin Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 53. Sartorius Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 54. SGS Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 55. Charles River Laboratories International Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 56. Clean Cells Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 57. Rad Source Technologies Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 58. Texcell Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 59. Viral Inactivated Plasma Systems Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 60. Wuxi Pharmatech (Cayman) Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Viral Inactivation in 2025?
The global market size of Viral Inactivation in 2025 was 662 Million USD.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Viral Inactivation market size from 2025 to 2031?
What was the global market size of Viral Inactivation in 2031?
Which companies rank high in the global Viral Inactivation market?
Related Reports
Viral Inactivation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Viral Inactivation was estimated to be worth US$ 662 million in 2025 and is projected to reach US$ 1283 million, growing at a CAGR of 10.1% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 120
USD 3950.00
(Single User License)
Global Viral Inactivation Market Research Report 2026
The global Viral Inactivation market was valued at US$ 662 million in 2025 and is anticipated to reach US$ 1283 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 117
USD 2900.00
(Single User License)
Global Viral Inactivation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Viral Inactivation market size was US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 91
USD 4250.00
(Single User License)
Viral Inactivation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Viral Inactivation was estimated to be worth US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 112
USD 3950.00
(Single User License)
Global Viral Inactivation Market Insights, Forecast to 2030
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published Date: 2024-04-25
Pages: 106
USD 4900.00
(Single User License)
Global Viral Inactivation Market Research Report 2024
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published Date: 2024-01-11
Pages: 84
USD 2900.00
(Single User License)
Viral Inactivation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Viral Inactivation was estimated to be worth US$ 662 million in 2025 and is projected to reach US$ 1283 million, growing at a CAGR of 10.1% from 2026 to 2032.
Published: 2026-07-15
Pages: 120
USD 3950.00 (Single User License)Global Viral Inactivation Market Research Report 2026
The global Viral Inactivation market was valued at US$ 662 million in 2025 and is anticipated to reach US$ 1283 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published: 2026-04-28
Pages: 117
USD 2900.00 (Single User License)Global Viral Inactivation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Viral Inactivation market size was US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 91
USD 4250.00 (Single User License)Viral Inactivation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Viral Inactivation was estimated to be worth US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 112
USD 3950.00 (Single User License)Global Viral Inactivation Market Insights, Forecast to 2030
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published: 2024-04-25
Pages: 106
USD 4900.00 (Single User License)Global Viral Inactivation Market Research Report 2024
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published: 2024-01-11
Pages: 84
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now